US 11,938,208 B2
Antimicrobial mixture
Imke Meyer, Bodenwerder (DE); and Ravikumar Pillai, Mahwah, NJ (US)
Assigned to Symrise AG, Holzminden (DE)
Appl. No. 17/435,103
Filed by SYMRISE AG, Holzminden (DE)
PCT Filed Mar. 29, 2019, PCT No. PCT/EP2019/058022
§ 371(c)(1), (2) Date Aug. 31, 2021,
PCT Pub. No. WO2020/182318, PCT Pub. Date Sep. 17, 2020.
Claims priority of provisional application 62/817,008, filed on Mar. 12, 2019.
Prior Publication US 2022/0362119 A1, Nov. 17, 2022
Int. Cl. A61K 8/34 (2006.01); A61K 8/24 (2006.01); A61K 8/35 (2006.01); A61K 8/92 (2006.01); A61P 31/00 (2006.01)
CPC A61K 8/347 (2013.01) [A61K 8/24 (2013.01); A61K 8/35 (2013.01); A61K 8/92 (2013.01); A61P 31/00 (2018.01)] 8 Claims
 
1. An antimicrobial mixture consisting of
(a) about 0.1 wt.-% of at least one α-bisabolol isomer,
(b) about 0.25 wt.-% to about 0.35 wt.-% of 4-hydroxyacetophenone, and
(c) the balance of at least one additional antimicrobial agent different from components (a) and (b),
on condition the amounts add to 100 wt.-%,
and present in an anti-microbially effective amount against mold species of the genus E. coli after 14 days at a minimum.